| pubmed-article:2794575 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2794575 | lifeskim:mentions | umls-concept:C0011220 | lld:lifeskim |
| pubmed-article:2794575 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
| pubmed-article:2794575 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:2794575 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:2794575 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
| pubmed-article:2794575 | pubmed:issue | 2 Suppl | lld:pubmed |
| pubmed-article:2794575 | pubmed:dateCreated | 1989-11-9 | lld:pubmed |
| pubmed-article:2794575 | pubmed:abstractText | Delta hepatitis is a relatively common in Egypt especially in patients with chronic liver disease. Delta virus infection is associated with a high frequency of hepatic decompensation and it seems to impose additional burden on liver function. It does not seem to be more prevalent in particular type of cirrhosis but the CAH pathology was found to be mostly associated with virus infection. HBV replication seems to be inhibited by the presence of delta virus as evidenced by the low frequency of HBe Ag in serum and HBs Ag in liver among patients with HDV infection. | lld:pubmed |
| pubmed-article:2794575 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2794575 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2794575 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2794575 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2794575 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2794575 | pubmed:issn | 0253-5890 | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:RefaatM AMA | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:AlyM AMA | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:EssaM HMH | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:MakaremS SSS | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:HelmsKK | lld:pubmed |
| pubmed-article:2794575 | pubmed:author | pubmed-author:MangoodA MAM | lld:pubmed |
| pubmed-article:2794575 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2794575 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:2794575 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2794575 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2794575 | pubmed:pagination | 869-78 | lld:pubmed |
| pubmed-article:2794575 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:meshHeading | pubmed-meshheading:2794575-... | lld:pubmed |
| pubmed-article:2794575 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2794575 | pubmed:articleTitle | The pattern of bilharzial infection with hepatitis B virus associated with delta agent. | lld:pubmed |
| pubmed-article:2794575 | pubmed:publicationType | Journal Article | lld:pubmed |
